Physician profile
Rishi Chatterji
NPI 1477177517
$14,892.18
in general payments reported to CMS, 2019-2025
11 companies · $5,731 in 2025
The $5,731 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.69 · 2021: $4,598 · 2022: $1,288 · 2023: $2,081 · 2024: $1,183 · 2025: $5,731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Food and Beverage: $2,639 · Travel and Lodging: $1,039 · Education: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Food and Beverage | $2,639.20 |
| Travel and Lodging | $1,039.27 |
| Education | $315.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,211.91 | 2025 | Real Intelligence, Renasys Touch, Pico 7 |
| Pinnacle, INC | $3,649.17 | 2021-2024 | |
| Medical Device Business Services, INC. | $3,350.59 | 2021-2024 | Actis, Inhance |
| Stryker Corporation | $1,195.69 | 2020-2025 | Ortholoc 3di, Gamma, Blueprint Patient Specific Instrumentation |
| Depuy Synthes Sales INC. | $646.23 | 2021-2025 | Na, Inhance, Dynacord |
| Zimmer Biomet Holdings, INC. | $340.70 | 2021-2024 | Persona, Osseotite, Rosa |
| Illuminoss Medical, INC. | $168.02 | 2024 | |
| Aroa Biosurgery Incorporated | $138.45 | 2024 | |
| Integra Lifesciences Corporation | $135.00 | 2021 | |
| Arthrex, INC. | $42.43 | 2024 | |
| Heraeus Medical, LLC. | $13.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rishi Chatterji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.